(Press-News.org) Philadelphia, April 10, 2024 – CAR T cell therapy has revolutionized the way certain types of cancer are treated, and the longer those CAR T cells live in a patient’s body, the more effectively they respond to cancer. Now, in a new study, researchers at Children’s Hospital of Philadelphia (CHOP) and Stanford Medicine have found that a protein called FOXO1 improves the survival and function of CAR T cells, which may lead to more effective CAR T cell therapies and could potentially expand its use in difficult-to-treat cancers. The findings were published online today by the journal Nature.
T cells are a type of immune cell that recognize and kill pathogens in order to protect the host. Cancer is often able to evade the body’s immune system, but as a result of CAR T cell therapy, a patient’s own T cells can be reprogrammed to recognize and kill these cancer cells, which has led to FDA-approved treatments for certain types of lymphomas and leukemias.
However, fewer than 50% of patients who receive CAR T cell therapy remain cured after a year. One of the reasons for this is that CAR T cells often don’t survive long enough in patients to completely eradicate their cancer. Prior research has demonstrated that patients who are cured through CAR T cell therapy often have CAR T cells that live longer and can more successfully fight cancerous cells.
To determine what helps CAR T cells live longer, researchers wanted to understand the underlying biology behind memory T cells, which are a type of natural T cell whose purpose is to persist and retain function. One protein of interest, FOXO1, which activates genes associated with T cell memory, has previously been studied in mice but remains under-researched in human T cells or CAR T cells.
“By studying factors that drive memory in T cells, like FOXO1, we can enhance our understanding of why CAR T cells persist and work more effectively in some patients compared to others,” said senior study author Evan Weber, PhD, an Assistant Professor of Pediatrics at the University of Pennsylvania Perelman School of Medicine and cell and gene therapy researcher within the CHOP Center for Childhood Cancer Research (CCCR) and the Center for Cellular and Molecular Therapeutics (CCMT).
To learn more about the role of FOXO1 in human CAR T cells, the researchers in this study used CRISPR to delete FOXO1. They found that in the absence of FOXO1, human CAR T cells lose their ability to form a healthy memory cell or protect against cancer in an animal model, supporting the notion that FOXO1 controls memory and antitumor activity.
Researchers then applied methods to force CAR T cells to overexpress FOXO1, which turned on memory genes and enhanced their ability to persist and fight cancer in animal models. In contrast, when the researchers overexpressed a different memory-promoting factor, there was no improvement in CAR T cell activity, suggesting that FOXO1 plays a more unique role in promoting T cell longevity.
Importantly, researchers also found evidence that FOXO1 activity in patient samples correlates with persistence and long-term disease control, thereby implicating FOXO1 in clinical CAR T cell responses.
“These findings may help improve the design of CAR T cell therapies and potentially benefit a wider range of patients,” Weber said. “We are now collaborating with labs at CHOP to analyze CAR T cells from patients with exceptional persistence to identify other proteins like FOXO1 that could be leveraged to improve durability and therapeutic efficacy.”
This study was supported by the National Cancer Institute Immunotherapy Discover and Development grants 1U01CA232361-A1, K08CA23188-01, U01CA260852, and U54CA232568-01; the National Human Genome Research Institute grant K99 HGHG012579 (C.A.L.); the Parker Institute for Cancer Immunotherapy; V Foundation for Cancer Research; Society for Immunotherapy of Cancer Rosenberg Scholar Award; Stand Up 2 Cancer - St. Baldrick's - NCI grant SU2CAACR-DT1113; and the Virginia and D.K. Ludwig Fund for Cancer Research and NCI grant U2C CA233285.
Doan et al, “FOXO1 is a master regulator of memory programming in CAR T cells.” Nature. Online April 10, 2024. DOI: 10.1038/s41586-024-07300-8.
About Children’s Hospital of Philadelphia:
A non-profit, charitable organization, Children’s Hospital of Philadelphia was founded in 1855 as the nation’s first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey, as well as the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia. In addition, its unique family-centered care and public service programs have brought Children’s Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu.
END
CHOP, Stanford researchers identify protein that controls CAR T cell longevity
FOXO1 is required for memory in T cells and is associated with more durable clinical responses to CAR T cell therapy
2024-04-10
ELSE PRESS RELEASES FROM THIS DATE:
Race, ethnicity, and delayed time to COVID-19 testing among health care workers
2024-04-10
About The Study: In this cross-sectional study of health care personnel (HCP), compared with non-Hispanic white HCP and clinical HCP with graduate degrees, non-Hispanic Black HCP, non-Hispanic HCP of other races, and HCP of all other professional and education backgrounds were more likely to have delayed COVID-19 testing. These findings suggest that time to testing may serve as a valuable metric in evaluating sociodemographic disparities in the response to COVID-19 and future health mitigation strategies.
Authors: DaMarcus ...
Trends in deaths of despair by race and ethnicity
2024-04-10
About The Study: As of 2022, the midlife mortality rates from deaths of despair (deaths from suicide, drug overdose, and alcoholic liver disease) among Black individuals were higher than rates among white individuals, and rates among American Indian or Alaska Native individuals remained higher than rates in the other groups. Rising inequalities in deaths of despair among American Indian or Alaska Native and Black individuals were largely attributable to disproportionate early mortality from drug- and alcohol-related causes, which increased leading up to and during the COVID-19 pandemic.
Authors: Joseph ...
Revolutionary molecular device unleashes potential for targeted drug delivery and self-healing materials
2024-04-10
In a new breakthrough that could revolutionise medical and material engineering, scientists have developed a first-of-its-kind molecular device that controls the release of multiple small molecules using force.
The researchers from The University of Manchester describe a force-controlled release system that harnesses natural forces to trigger targeted release of molecules, which could significantly advance medical treatment and smart materials.
The discovery, published today in the journal Nature, uses a novel technique using a type of interlocked molecule known as rotaxane. Under the influence of mechanical force - such ...
The genesis of our cellular skeleton, image by image
2024-04-10
Cells contain various specialised structures - such as the nucleus, mitochondria or peroxisomes - known as “organelles’’. Tracing their genesis and determining their structure is fundamental to understanding cell function and the pathologies linked to their dysfunction. Scientists at the University of Geneva (UNIGE) have combined high resolution microscopy and kinematic reconstruction techniques to visualise, in motion, the genesis of the human centriole. This organelle, essential to the organisation of the cell skeleton, is associated - in case of dysfunction - with certain cancers, brain disorders or retinal diseases. This work, published in the journal Cell, elucidates ...
Quantum breakthrough when light makes materials magnetic
2024-04-10
The potential of quantum technology is huge but is today largely limited to the extremely cold environments of laboratories. Now, researchers at Stockholm University, at the Nordic Institute for Theoretical Physics and at the Ca’ Foscari University of Venice have succeeded in demonstrating for the very first time how laser light can induce quantum behavior at room temperature – and make non-magnetic materials magnetic. The breakthrough is expected to pave the way for faster and more energy-efficient computers, information transfer and data storage.
Within a few decades, the advancement of quantum technology ...
Living near green space associated with fewer emotional problems in preschool-age kids, NIH study finds
2024-04-10
Children who live in areas with natural spaces (e.g., forests, parks, backyards) from birth may experience fewer emotional issues between the ages of 2 and 5, according to a study funded by the NIH Environmental Influences on Child Health Outcomes (ECHO) program.
While research has suggested that time in nature is important for mental health, studies examining the effects on young children are limited. ECHO investigators addressed this research gap by analyzing information from parents about the behavior of their children from ages 2 to 11. They combined this data with the family’s ...
Researchers explore role of androgens in shaping sex differences
2024-04-10
Sex differences are widespread across human development, physiological processes, and diseases, making it important to characterize the impact of sex differences in these areas. Understanding the regulatory mechanisms associated with these differences, including the role of androgens, is also vital for clinical translation—especially for diseases more prevalent in one sex.
To answer these questions, a team led by Prof. GAO Dong and Prof. CHEN Luonan from the Center for Excellence in Molecular Cell Science, Shanghai Institute ...
Quantum crystal of frozen electrons—the Wigner crystal—is visualized for the first time
2024-04-10
Electrons—these infinitesimally small particles that are known to zip around atoms—continue to amaze scientists despite the more than a century that scientists have studied them. Now, physicists at Princeton University have pushed the boundaries of our understanding of these minute particles by visualizing, for the first time, direct evidence for what is known as the Wigner crystal—a strange kind of matter that is made entirely of electrons.
The finding, published in the April 11th issue of the journal Nature, confirms a 90-year-old ...
A new coating method in mRNA engineering points the way to advanced therapies
2024-04-10
Researchers from Tokyo Medical and Dental University (TMDU) have developed a novel method for chemically modifying engineered messenger RNA molecules, allowing greater control of their biological functions and advancing mRNA therapeutic technologies
Tokyo, Japan – Medicine can help to treat certain illnesses, e.g., antibiotics can help overcome infections, but a new, promising field of medicine involves providing our body with the “blueprint” for how to defeat illnesses on its own.
mRNA therapeutics ...
Stanford Medicine study flags unexpected cells in lung as suspected source of severe COVID
2024-04-10
The lung-cell type that’s most susceptible to infection by SARS-CoV-2, the virus that causes COVID-19, is not the one previously assumed to be most vulnerable. What’s more, the virus enters this susceptible cell via an unexpected route. The medical consequences may be significant.
Stanford Medicine investigators have implicated a type of immune cell known as an interstitial macrophage in the critical transition from a merely bothersome COVID-19 case to a potentially deadly one. Interstitial macrophages are situated deep in the lungs, ...
LAST 30 PRESS RELEASES:
Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment
New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment
Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor
Study prompts new theory of human-machine communication
New method calculates rate of gene expression to understand cell fate
Researchers quantify rate of essential evolutionary process in the ocean
Innovation Crossroads companies join forces, awarded U.S. Air Force contract
Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations
Pioneering advances in in vivo CAR T cell production
Natural medicines target tumor vascular microenvironment to inhibit cancer growth
Coral-inspired pill offers a new window into the hidden world of the gut
nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high
When getting a job makes you go hungry
Good vibrations could revolutionize assisted reproductive technology
More scrutiny of domestic fishing fleets at ports could help deter illegal fishing
Scientists transform plastic waste into efficient CO2 capture materials
Discovery of North America’s role in Asia’s monsoons offers new insights into climate change
MD Anderson and Phoenix SENOLYTIX announce strategic cross-licensing agreement to enhance inducible switch technologies for cell and gene therapies
Researchers discover massive geo-hydrogen source to the west of the Mussau Trench
Even untouched ecosystems are losing insects at alarming rates, new study finds
Adaptive visible-infrared camouflage with wide-range radiation control for extreme ambient temperatures
MD Anderson research highlights for September 5, 2025
Physicists create a new kind of time crystal that humans can actually see
Reminder: Final media invitation for EPSC-DPS2025 and details of media briefings on RAMSES and Juno missions
Understanding orderly and disorderly behavior in 2D nanomaterials could enable bespoke design, tailored by AI
JAMA Network launches JAMA+ Women's Health
Surface plasmon driven atomic migration mediated by molecular monolayer
ERC Starting Grant for five University of Groningen scientists
AI turns printer into a partner in tissue engineering
What climate change means for the Mediterranean Sea
[Press-News.org] CHOP, Stanford researchers identify protein that controls CAR T cell longevityFOXO1 is required for memory in T cells and is associated with more durable clinical responses to CAR T cell therapy